MicroPort CardioFlow Medtech Corporation (2160.HK) has a MoatMap StockRank of 16/100 based on Quality (40/100), Value (41/100), and Momentum (20/100) factor scores. The current signal is STRONG SELL. Chinese healthcare company with a 'STRONG_SELL' signal. As an EM firm, it is a casualty of 'Dollar Dominance, EM Strain'. No clear, unpriced asymmetric macro tailwind from the identified themes.